Dr. Lal PathLabs Ltd arm to acquire Bindish Diagnostic Laboratory LLP

PathLabs Unifiers Private Limited ("PUPL") (a wholly owned subsidiary of Dr. Lal PathLabs Ltd) has signed binding term sheets on 6 November, 2020 for the acquisitions of the business of Bindish Diagnostic Laboratory LLP ("BDL"), in Jamnagar, Gujarat on a going concern basis, for a purchase consideration not exceeding INR 40 million and equity stake of 70% in ChanRe Diagnostic Services Private Limited ("CDSPL"), in Bengaluru, Karnataka, for a purchase consideration not exceeding INR 175 million. BDL and CDSPL are engaged in the business of providing pathological diagnostic services.

Shares of Dr. Lal PathLabs Ltd was last trading in BSE at Rs.2270 as compared to the previous close of Rs. 2320.7. The total number of shares traded during the day was 13693 in over 1952 trades.

The stock hit an intraday high of Rs. 2375.2 and intraday low of 2265.95. The net turnover during the day was Rs. 31781546.

Source : Equity Bulls

Keywords